IMMUNOTHERAPY COMBINATIONS IN STAGE IV CANCER: SYNERGISTIC EFFECTS AND CLINICAL OUTCOMES. (2026). Frontier in Medical and Health Research, 4(1), 94-107. https://fmhr.net/index.php/fmhr/article/view/1989